A murine-human chimeric IgG antibody against vascular endothelial growth factor receptor 2 inhibits angiogenesis in vitro.

about

A murine-human chimeric IgG antibody against vascular endothelial growth factor receptor 2 inhibits angiogenesis in vitro.

Item

http://www.wikidata.org/entity/Q38597921

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

A murine-human chimeric IgG an ...... nhibits angiogenesis in vitro.

@en

type

Item

label

A murine-human chimeric IgG an ...... nhibits angiogenesis in vitro.

@en

prefLabel

A murine-human chimeric IgG an ...... nhibits angiogenesis in vitro.

@en

P1476

A murine-human chimeric IgG an ...... nhibits angiogenesis in vitro.

@en

P2093

Guipeng Ding

http://www.w3.org/2001/XMLSchema#string

Jin Zhu

http://www.w3.org/2001/XMLSchema#string

Ximin Chen

http://www.w3.org/2001/XMLSchema#string

Zhenqing Feng

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo anti-angiogenic activities of Panduratin A

The structural basis for the function of two anti-VEGF receptor 2 antibodies

Angiogenesis as a therapeutic target

Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.

A human Fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo.

Clinical translation of angiogenesis inhibitors.

Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice.

Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity

Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy

VEGF is essential for the growth and migration of human hepatocellular carcinoma cells.

P2888

s10616-013-9587-x

P304

395-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10616-013-9587-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1050914908

http://www.w3.org/2001/XMLSchema#string

P698

23881538

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

3973788

http://www.w3.org/2001/XMLSchema#string